Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy

• Autori principali: Nazila FATHI MAROUFI (Autore), Amir GHORBANIHAGHJO (Autore), Manizheh SAYYAH MELLI (Autore), Maryam VAEZI (Autore), Zohreh HEKMATI AZAR MEHRABANI (Autore), Maryam BANNAZADEH AMIRKHIZ (Autore), Nadereh RASHTCHIZADEH (Autore)
• Natura: Libro
• Pubblicazione: Tehran University of Medical Sciences, 2017-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Pregnancy Associated Osteoporosis (PAO) can lead to serious difficulties such as fragility fractures, elongated back pain and height loss in affected women. Soluble Receptor Activator of Nuclear Factor-Kappa B ligand (sRANKL) to Osteoprotegerin (OPG) ratio is chosen as a bone metabolism...